The aim of this study was to compare the levels of certain analytes, including IL-6, TNF-α, CRP, visfatin, progranulin, and 25(OH)-vitamin D, across three distinct groups, namely PD patients without dyskinesia, PD patients with dyskinesia, and healthy controls. This evidence concerns the gene NAMPT and Parkinson disease.